Genetic remodeling in tumor formation
A new study demonstrates the ability of the mutant Kras oncogene to use genetic reprogramming to make cells more stem-like and plastic; it resolves the long-standing debate over why Kras is so special in tumor formation. They were also able to identify an effector complex that can be targeted for therapeutic treatment against mutant Kras.
Materials provided by Terasaki Institute for Biomedical Innovation. Note: Content may be edited for style and length.
Source link aaaaa